Ovarian Cancer Stage IV Clinical Trials

8 recruiting

Ovarian Cancer Stage IV Trials at a Glance

8 actively recruiting trials for ovarian cancer stage iv are listed on ClinicalTrialsFinder across 6 cities in 4 countries. The largest study group is Phase 2 with 3 trials, with the heaviest enrollment activity in Boston, Middletown, and Commack. Lead sponsors running ovarian cancer stage iv studies include Charles University, Czech Republic, Dana-Farber Cancer Institute, and Brigham and Women's Hospital.

Browse ovarian cancer stage iv trials by phase

Treatments under study

About Ovarian Cancer Stage IV Clinical Trials

Looking for clinical trials for Ovarian Cancer Stage IV? There are currently 8 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Ovarian Cancer Stage IV trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Ovarian Cancer Stage IV clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 18 of 8 trials

Recruiting
Phase 2

Study of Acute Normovolemic Hemodilution (ANH) in People With Ovarian Cancer Who Are Having Cytoreductive Surgery

Ovarian CancerOvarian CarcinomaFallopian Tube Cancer+7 more
Memorial Sloan Kettering Cancer Center86 enrolled7 locationsNCT06290193
Recruiting
Phase 3

Prehabilitation in Gynaecological Cancer Patients

Ovarian CancerEndometrial CancerOvarian Cancer Stage III+2 more
Charles University, Czech Republic64 enrolled1 locationNCT04789694
Recruiting
Phase 2

Tart Cherry Juice as a Dietary Supplement for the Prevention of Paclitaxel-Induced Neuropathy

Breast CancerBreast CarcinomaBreast Neoplasm+34 more
University of California, Davis86 enrolled1 locationNCT06268665
Recruiting
Not Applicable

Exercise as a Preventive Agent to Combat Immobility in Patients With Ovarian or Endometrial Cancers Receiving Chemotherapy

Ovarian CancerEndometrial CancerOvarian Carcinoma+4 more
Dana-Farber Cancer Institute30 enrolled1 locationNCT04997096
Recruiting
Not Applicable

Predicting Outcome of Cytoreduction in Advanced Ovarian Cancer

Ovarian Cancer Stage IIIOvarian Cancer Stage IV
Fondazione Policlinico Universitario Agostino Gemelli IRCCS151 enrolled1 locationNCT06017557
Recruiting
Phase 1Phase 2

Sequential CD146 and GPC3 CAR-T Cell Therapy in Advanced Ovarian Cancer

Ovarian CancerOvarian CarcinomaOvarian Cancer Stage IV+1 more
Essen Biotech80 enrolled1 locationNCT07067255
Recruiting
Phase 1

Microdevice In Ovarian, Fallopian Tube, And Peritoneal Cancer

Ovarian CancerFallopian Tube CancerOvarian Cancer Stage III+4 more
Brigham and Women's Hospital20 enrolled2 locationsNCT04701645
Recruiting

Tumor Microenvironment in Ovarian Cancer

Ovarian Cancer Stage IIIOvarian Cancer Stage IV
University of Udine50 enrolled1 locationNCT06272240